This is because RHAMM, working in concert with BRCA1 and BRAC2, can significantly promote tumor growth and metastasis for pancreatic cancer [62] in vivo, and multiple other cancer types such as basal-like breast cancer [63] and glioma [64] in vivo. This evidence concerns the gene BRCA1 and breast cancer.